Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 0 | 0 | 6.7M | 4.0M |
| Cost of revenue | — | — | 4.0M | 2.6M |
| Gross profit | — | — | 2.7M | 1.3M |
| Operating expense | ||||
| Research & development | 3.9M | 5.7M | 3.3M | 4.9M |
| Selling general and admin | 5.2M | 5.2M | 7.8M | 7.5M |
| Other operating expenses | — | — | — | — |
| Operating income | -9.1M | -10.9M | -8.4M | -11.0M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | 169.9K | 127.3K |
| Other income expense | 1.2M | 9.1M | 492.2K | 369.5K |
| Pretax income | -7.9M | -1.8M | -8.1M | -10.8M |
| Tax provision | — | — | 453.1K | 162.4K |
| Net income | -7.9M | -8.9M | -8.5M | -11.0M |
| Basic EPS | -0.1 | -0.1 | — | -0.1 |
| Diluted EPS | -0.1 | -0.1 | — | -0.1 |
| Basic average shares | 146.4M | 146.4M | — | 146.4M |
| Diluted average shares | 146.4M | 146.4M | — | 146.4M |
| EBITDA | -10.0M | -19.8M | -8.2M | -10.7M |
| Net income from continuing op. | -7.9M | -8.9M | -8.5M | -11.0M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |